down arrow

Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
77.00
-1 (-1.28%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 1.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Coral Labs.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Oxygenta Pharma
Pharmaids Pharma
Ambalal Sarabhai
Sanjiv.Parant.
Mankind Pharma
Why is Oxygenta Pharmaceutical Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 35.68% and Operating profit at 0% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 94.89%, its profits have risen by 97.6%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Oxygenta Pharma for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Oxygenta Pharma
94.89%
1.91
49.69%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
35.68%
EBIT Growth (5y)
-17.32%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
-42.44%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
-14.33
EV to EBIT
-27.49
EV to EBITDA
-34.87
EV to Capital Employed
9.34
EV to Sales
4.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.41%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
NET SALES(Q)

Highest at Rs 33.21 cr

-6What is not working for the Company
PBDIT(Q)

Lowest at Rs -4.35 cr.

PBT LESS OI(Q)

Lowest at Rs -5.45 cr.

PAT(Q)

At Rs -3.93 cr has Fallen at -5.4%

Loading Valuation Snapshot...
Here's what is working for Oxygenta Pharma
Net Sales - Quarterly
At Rs 33.21 cr has Grown at 262.95%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
Highest at Rs 33.21 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Oxygenta Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -5.45 cr has Fallen at -54.39%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -4.35 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -5.45 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -3.93 cr has Fallen at -5.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)